| The neuroactive potential of the human gut microbiota in quality of life and depression |
170 |
| Dynamic root exudate chemistry and microbial substrate preferences drive patterns in rhizosphere microbial community assembly |
156 |
| Gut microbiome structure and metabolic activity in inflammatory bowel disease |
109 |
| Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus |
98 |
| Enterotypes in the landscape of gut microbial community composition |
98 |
| Recovery of genomes from metagenomes via a dereplication, aggregation and scoring strategy |
77 |
| GABA-modulating bacteria of the human gut microbiota |
75 |
| Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease |
74 |
| The current and future global distribution and population at risk of dengue |
73 |
| Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread |
71 |
| Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans |
61 |
| Nitrogen-fixing populations of Planctomycetes and Proteobacteria are abundant in surface ocean metagenomes |
59 |
| Tracking virus outbreaks in the twenty-first century |
58 |
| Antibiotic-resistant bacteria show widespread collateral sensitivity to antimicrobial peptides |
57 |
| Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli |
54 |
| Recovery of gut microbiota of healthy adults following antibiotic exposure |
53 |
| The discovery of Bombali virus adds further support for bats as hosts of ebolaviruses |
53 |
| Global diversity and biogeography of bacterial communities in wastewater treatment plants |
53 |
| Modelling Cryptosporidium infection in human small intestinal and lung organoids |
52 |
| Defining and combating antibiotic resistance from One Health and Global Health perspectives |
51 |
| Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host |
50 |
| HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy |
48 |
| The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification |
47 |
| FtsW is a peptidoglycan polymerase that is functional only in complex with its cognate penicillin-binding protein |
44 |
| An automated Raman-based platform for the sorting of live cells by functional properties |
42 |
| Phage puppet masters of the marine microbial realm |
42 |
| Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis |
41 |
| Dynamics of metatranscription in the inflammatory bowel disease gut microbiome |
41 |
| Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis |
39 |
| Culture-independent discovery of the malacidins as calcium-dependent antibiotics with activity against multidrug-resistant Gram-positive pathogens |
39 |
| Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model |
37 |
| Proposal of the reverse flow model for the origin of the eukaryotic cell based on comparative analyses of Asgard archaeal metabolism |
37 |
| Dietary pectic glycans are degraded by coordinated enzyme pathways in human colonic Bacteroides |
37 |
| Host-linked soil viral ecology along a permafrost thaw gradient |
36 |
| Discovery of an expansive bacteriophage family that includes the most abundant viruses from the human gut |
35 |
| Retraction of DNA-bound type IV competence pili initiates DNA uptake during natural transformation in Vibrio cholerae |
34 |
| Decoding type I and III interferon signalling during viral infection |
33 |
| Cryptic inoviruses revealed as pervasive in bacteria and archaea across Earth's biomes |
32 |
| Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity |
30 |
| REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes |
30 |
| AXL promotes Zika virus infection in astrocytes by antagonizing type I interferon signalling |
30 |
| Differential depth distribution of microbial function and putative symbionts through sediment- hosted aquifers in the deep terrestrial subsurface |
29 |
| Drug repurposing for antimicrobial discovery |
29 |
| Defective viral genomes are key drivers of the virus-host interaction |
28 |
| Characterization of a filovirus (Mengla virus) from Rousettus bats in China |
28 |
| Stability of the human faecal microbiome in a cohort of adult men |
28 |
| Vector biology meets disease control: using basic research to fight vector-borne diseases |
27 |
| DISARM is a widespread bacterial defence system with broad anti-phage activities |
27 |
| A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication |
27 |
| A systematic review of biomarkers to detect active tuberculosis |
27 |
